Author/Authors :
Liu، نويسنده , , Tsun-Jui and Hsueh، نويسنده , , Chung-Whei and Lee، نويسنده , , Wen-Lieng and Lai، نويسنده , , Hui-Chin and Wang، نويسنده , , Kuo-Yang and Ting، نويسنده , , Chih-Tai، نويسنده ,
Abstract :
Amiodarone, used in conjunction with percutaneous balloon mitral commissurotomy, can safely convert rheumatic atrial fibrillation in 38% of patients compared with 0% in those without it. However, whether this treatment exerts long-term benefits on prognosis awaits further investigation.
